Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  caspofungin acetate
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-4 of 4 for your search:
Start Over
Empirical Versus Preemptive Antifungal Therapy
Phase: Phase III
Type: Biomarker/Laboratory analysis, Health services research, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-65091-06093, 2010-020814-27, MK-0991-070, EORTC-65091, EORTC-06093, EU-21102, EUDRACT-2010-020814-27, MERCK-EORTC-65091, NCT01288378
Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 3 months to 30 years
Sponsor: NCI, Other
Protocol IDs: ACCL0933, NCI-2011-02640, CDR0000695748, COG-ACCL0933, U10CA095861, NCT01307579
Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant
Phase: Phase III
Type: Supportive care
Status: Active
Age: 3 months to 20 years
Sponsor: NCI, Other
Protocol IDs: ACCL1131, NCI-2012-00102, CDR0000721415, COG-ACCL1131, U10CA095861, NCT01503515
Caspofungin Based Combined Anti-fungal Therapy for Proven or Probable Invasive Fungal Infection
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 to 55
Sponsor: Other
Protocol IDs: RJH-2011-71, NCT01501708
Start Over